Atlas Trials

CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 4

Clinical trial NCT05066789 · TERMINATED

Trial details

NCT number
NCT05066789
Sponsor
Samsung Medical Center
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Coronary Artery Disease
Start date
2022-01-17
Primary completion
2024-03-22
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.